Results 21 to 30 of about 56,021 (251)

Kawasaki Syndrome [PDF]

open access: yesClinical Infectious Diseases, 1999
KS is a fascinating illness of childhood that has emerged over the last 30 years and is now recognized as the most common cause of acquired heart disease in children in the United States. It has a dramatic clinical presentation in most cases, but for a small number of cases that present with a more subtle disease there appears to be a greater risk of ...
W H, Mason, M, Takahashi
openaire   +2 more sources

Kawasaki Disease

open access: yesActa Paediatrica, 1991
SummaryIn this review, I have outlined the clinical picture, epidemiology, pathology, etiology, and current treatment and management of Kawasaki disease. The disease in question has unique features which cannot be classified into any of the categories of conventional pediatric diseases, and thus the elucidation of the etiology and mode of onset may ...
openaire   +8 more sources

Atypical recurrent kawasaki disease with retropharyngeal involvement: A case study and literature review

open access: yesAnnals of Pediatric Cardiology, 2020
Kawasaki disease (KD) is a systemic inflammatory condition primarily affecting young children. We present an adolescent male with two episodes of complete KD between the age of 2 and 14 years.
Rachel K Cason   +3 more
doaj   +1 more source

The Epidemiology and Pathogenesis of Kawasaki Disease

open access: yesFrontiers in Pediatrics, 2018
Epidemiologic and clinical features of Kawasaki Disease (KD) strongly support an infectious etiology. KD is worldwide, most prominently in Japan, Korea, and Taiwan, reflecting increased genetic susceptibility among Asian populations.
Anne H. Rowley, Stanford T. Shulman
doaj   +1 more source

Progress in functional mechanisms and biomarkers of miRNA related to Kawasaki disease

open access: yesShanghai Jiaotong Daxue xuebao. Yixue ban, 2023
Kawasaki disease is an acute febrile exanthema pediatric disease with systemic vasculitis as the main lesion, which is the most common cause of acquired heart disease in children.
FENG Jiali, PENG Yu, DUAN Junkai
doaj   +1 more source

Post-COVID-19 Kawasaki-Like Vasculitis and Endocarditis: A Case Report

open access: yesPanorama of Emergency Medicine
Background: Coronavirus Disease of 2019 (COVID-19) can cause mild to severe infection, but with a combination of inflammatory complications that target virtually anywhere in the body.
Hilal Abdessamad   +7 more
doaj   +1 more source

NUEVOS HORIZONTES EN EL TRATAMIENTO DE LA ENFERMEDAD DE KAWASAKI

open access: yesBiociencias, 2019
La enfermedad de Kawasaki, es una vasculitis auto limitada que afecta principalmente a niños pequeños; Es la segunda causa más común de vasculitis en menores de 5 años.
Cristina Muñoz Otero
doaj   +1 more source

Evaluating the Impact of Sister City Cooperation between Bandung and Kawasaki on Environmental Sustainability

open access: yesJournal of Paradiplomacy and City Networks
This research provided an in-depth analysis of the role of paradiplomacy practiced by the Government of South Sulawesi Province in enhancing agricultural exports to Egypt.
Cholifatul Latifah Sabati
doaj   +1 more source

Calculating the fraction of Kawasaki disease potentially attributable to seasonal pathogens: a time series analysisResearch in context

open access: yesEClinicalMedicine, 2023
Summary: Background: Kawasaki disease is an acute, febrile, systemic vasculitis of children that primarily affects medium-sized blood vessels with a tropism for the coronary arteries. Although the etiological factors remain unknown, infections have been
Zaba Valtuille   +11 more
doaj   +1 more source

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients With Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; ClinicalTrials.gov identifier ...
Hermine I. Brunner   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy